Table 1 Clinical characteristics of PPCM patients
Anti-M2-R (+) group n = 48 | Anti-M2-R (−) group n = 59 | p value | |
|---|---|---|---|
Age (years) | 30.1± 3.6 | 29.5 ± 3.7 | 0.383 |
Multiple gestation | 14 | 15 | 0.665 |
Multiparity | 28 | 33 | 0.803 |
Pregnancy complications | |||
Pregnancy-induced hypertension | 19 | 22 | 0.808 |
Gestational diabetes mellitus | 12 | 16 | 0.804 |
Postpartum diagnosed PPCM | 29 | 33 | 0.640 |
Blood pressure (mm Hg) | |||
Systolic | 137.2 ± 13.3 | 136.5 ± 14.5 | 0.779 |
Diastolic | 88.0 ± 10.2 | 87.5 ± 10.7 | 0.797 |
Heart rate (bpm) | 96.0 ± 6.4 | 102.7 ± 6.1 | < 0.001 |
NYHA functional class | 2.85 ± 0.73 | 2.88 ± 0.71 | 0.834 |
Echocardiographic data | |||
LVEDD (mm) | 60.7 ± 5.6 | 60.4 ± 5.8 | 0.823 |
LVESD (mm) | 47.3 ± 6.1 | 47.0 ± 6.7 | 0.809 |
LVEF (%) | 38.0 ± 4.9 | 38.2 ± 3.2 | 0.763 |
HFmrEF | 25 | 24 | 0.216 |
Six-minute walk distance (m) | 195.9 ± 83.2 | 199.8 ± 78.0 | 0.802 |
NT-proBNP (pg/mL) | 4017.2 ± 1583.3 | 4411.0 ± 1838.2 | 0.253 |
Creatine (µmol/L) | 64.6 ± 10.6 | 66.7 ± 12.0 | 0.364 |